Stay updated on Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.

Latest updates to the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page
- ChecktodayChange DetectedThe page's revision tag updated from v3.5.4 to v3.5.5 in the site metadata. This indicates a platform update rather than any modification to the study content.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe study record revision was updated from v3.5.3 to v3.5.4, reflecting a new document revision in the study history. This change indicates an update to the study documentation on ClinicalTrials.gov.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page shows a revision update from v3.5.2 to v3.5.3, indicating a minor metadata/build change. This does not modify the study details or content presented on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedRevision: v3.5.2 was added and Revision: v3.5.0 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedPage revision updated to v3.5.0.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy for Metastatic Cancers with CDK12 Mutations Clinical Trial page.